Association between TNF and IL-1 bloc polymorphisms and plasma MCP-1 concentration

Atherosclerosis

Volumn 192, Issue 2, 2007, Pages 348-353

  Berrahmoune, Hind ^a,b   Herbeth, Bernard ^a,b   Lamont, John V ^c   Fitzgerald, Peter S ^c   Visvikis Siest, Sophie ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c Randox Laboratories Ltd   (United Kingdom)

Author keywords

Atherosclerosis; Inflammatory markers; Interleukins; MCP 1; Polymorphisms; Risk factor; Tumor necrosis factors

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN DERIVATIVE; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ANALYZER; ARTICLE; BIOCHIP; CELL COUNT; COMPARATIVE STUDY; FAMILY STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEMATOCRIT; HUMAN; HUMAN CELL; MALE; MODULATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; SEX; SMOKING; STATISTICAL SIGNIFICANCE;

ADULT; CHEMOKINE CCL2; FEMALE; HAPLOTYPES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; LYMPHOTOXIN-ALPHA; MALE; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248341839     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.05.015     Document Type: Article

References (48)

1. Krishnaswamy G., Kelley J., Yerra L., Smith J.K., and Chi D.S. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interfer Cytok Res 19 (1999) 91-104
2. Rollins B.J. Chemokines. Blood 90 (1997) 909-928
3. Tabata T., Mine S., Kawahara C., Okada Y., and Tanaka Y. Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells. Biochem Biophys Res Commun 305 (2003) 380-385
4. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88 (1991) 5252-5256
5. Ballantyne C.M., and Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl 6 (2005) 21-29
6. Dupuis J., Larson M.G., Vasan R.S., et al. Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q. Atherosclerosis 182 (2005) 307-314
7. Berrahmoune H., Lamont J., Fitzgerald P., and Visvikis-Siest S. Inter-individual variation of inflammatory markers of cardiovascular risks and diseases. Clin Chem Lab Med 43 (2005) 671-684
8. Berrahmoune H., Lamont J.V., Herbeth B., FitzGerald P.S., and Visvikis-Siest S. Biological determinants of and reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: results from the STANISLAS cohort. Clin Chem 52 (2006) 504-510
9. Chuluyan H.E., Lang B.J., Yoshimura T., Kenney J.S., and Issekutz A.C. Chemokine production and adhesion molecule expression by neural cells exposed to IL-1, TNF alpha and interferon gamma. Life Sci 63 (1998) 1939-1952
10. Jarai G., Sukkar M., Garrett S., et al. Effects of interleukin-1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays. Eur J Pharmacol 497 (2004) 255-265
11. Nasu K., Fukuda J., Sun B., Nishida M., and Miyakawa I. Interleukin-13 and tumor necrosis factor-beta differentially regulate the production of cytokines by cultured human endometrial stromal cells. Fertil Steril 79 Suppl 1 (2003) 821-827
12. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
13. Lieb K., Kaltschmidt C., Kaltschmidt B., et al. Interleukin-1 beta uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor alpha genes in the human astrocytoma cell line U373. J Neurochem 66 (1996) 1496-1503
14. Xu Y.X., Pindolia K.R., Janakiraman N., Chapman R.A., and Gautam S.C. Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 11 (1997) 49-62
15. D'Alfonso S., and Richiardi P.M. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39 (1994) 150-154
16. Nicklin M.J., Weith A., and Duff G.W. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 19 (1994) 382-384
17. Abraham L.J., and Kroeger K.M. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66 (1999) 562-566
18. Messer G., Spengler U., Jung M.C., et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 173 (1991) 209-219
19. Pociot F., Molvig J., Wogensen L., Worsaae H., and Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 22 (1992) 396-402
20. Shirodaria S., Smith J., McKay I.J., Kennett C.N., and Hughes F.J. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res 79 (2000) 1864-1869
21. Wilson A.G., di Giovine F.S., Blakemore A.I., and Duff G.W. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1 (1992) 353
22. Dominici R., Cattaneo M., Malferrari G., et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 54 (2002) 82-86
23. Majetschak M., Flohe S., Obertacke U., et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 230 (1999) 207-214
24. Stuber F., Petersen M., Bokelmann F., and Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 24 (1996) 381-384
25. Suzuki G., Izumi S., Hakoda M., and Takahashi N. LTA 252G allele containing haplotype block is associated with high serum C-reactive protein levels. Atherosclerosis 176 (2004) 91-94
26. Siest G., Visvikis S., Herbeth B., et al. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas cohort. Clin Chem Lab Med 36 (1998) 35-42
27. Ponthieux A., Herbeth B., Droesch S., Haddy N., Lambert D., and Visvikis S. Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study. Atherosclerosis 172 (2004) 299-308
28. Fitzgerald S.P., Lamont J.V., McConnell R.I., and Benchikh E.O. Development of a high-throughput automated analyzer using biochip array technology. Clin Chem 51 (2005) 1165-1176
29. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16 (1988) 1215
30. Cheng S., Grow M.A., Pallaud C., et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 9 (1999) 936-949
31. Tiret L., Amouyel P., Rakotovao R., Cambien F., and Ducimetiere P. Testing for association between disease and linked marker loci: a log-linear-model analysis. Am J Hum Genet 48 (1991) 926-934
32. Nei M. Molecular evolutionary genetics (1987), Columbia University Press, New York
33. Tregouet D.A., Barbaux S., Escolano S., et al. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 11 (2002) 2015-2023
34. Tregouet D.A., Escolano S., Tiret L., Mallet A., and Golmard J.L. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet 68 (2004) 165-177
35. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398 (1999) 718-723
36. McDevitt H., Munson S., Ettinger R., and Wu A. Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity. Arthrit Res 4 Suppl 3 (2002) S141-S152
37. Smith C.A., Farrah T., and Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76 (1994) 959-962
38. Barath P., Fishbein M.C., Cao J., Berenson J., Helfant R.H., and Forrester J.S. Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am J Pathol 137 (1990) 503-509
39. Schreyer S.A., Vick C.M., and LeBoeuf R.C. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J Biol Chem 277 (2002) 12364-12368
40. Ferrari R. The role of TNF in cardiovascular disease. Pharmacol Res 40 (1999) 97-105
41. Bernard V., Pillois X., Dubus I., et al. The -308 G/A tumor necrosis factor-alpha gene dimorphism: a risk factor for unstable angina. Clin Chem Lab Med 41 (2003) 511-516
42. Howell W.M., Turner S.J., Collins A., Bateman A.C., and Theaker J.M. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population. Eur J Immunogenet 29 (2002) 17-23
43. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94 (1997) 3195-3199
44. Ozaki K., Ohnishi Y., Iida A., et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32 (2002) 650-654
45. Stuber F., Petersen M., Bokelmann F., and Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 24 (1996) 381-384
46. Bouma G., Crusius J.B., Oudkerk P.M., et al. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 43 (1996) 456-463
47. Temple S.E., Cheong K.Y., Almeida C.M., Price P., and Waterer G.W. Polymorphisms in lymphotoxin alpha and CD14 genes influence TNFalpha production induced by Gram-positive and Gram-negative bacteria. Genes Immun 4 (2003) 283-288
48. Mizuno H., Sato H., Sakata Y., et al. Impact of atherosclerosis-related gene polymorphisms on mortality and recurrent events after myocardial infarction. Atherosclerosis 185 (2005) 400-405